This case report describes the birth of a healthy infant after cryopreservation of zygotes produced by in-vitro matured oocytes retrieved from an anovulatory woman with polycystic ovarian syndrome (PCOS). To initiate the treatment cycle, the patient received intravaginal progesterone at night for 10 days to induce a withdrawal bleed. Oocyte retrieval was performed on day 11 following a withdrawal bleed. The patient was administered 10 000 IU of HCG subcutaneously 36 h prior to oocyte collection. A total of 63 immature oocytes were obtained; 10 were morphologically abnormal. Following incubation for 24-48 h in the maturation medium, TC-199 supplemented with 20% patient's own serum, 75 mIU/ml FSH and LH, 77.4% (41/53) of the oocytes were at the metaphase-II stage. Thirty-one (31/41, 75.6%) were fertilized using ICSI with her husband's spermatozoa, 15 fertilized oocytes were cultured for embryo transfer and 16 were frozen at the pronuclear stage. Pregnancy ensued following fresh embryo transfer. Unfortunately, the pregnancy was miscarried eight weeks later. However, the second frozenthawed embryo transfer attempt resulted in a full-term pregnancy with delivery of a healthy male infant.
Introduction
before immature oocyte retrieval in PCOS patients improves oocyte maturation, fertilization, embryo development and Women with polycystic ovarian syndrome (PCOS) are pregnancy rates (Chian et al., 1999 (Chian et al., , 2000 . However, it is still characterized by abnormal endocrine parameters, anovulation, unclear whether the embryos produced by in-vitro matured numerous antral follicles within their ovaries and frequently oocytes can be frozen for further embryo transfer. In this case infertility (Goldzieher and Green, 1962) . Patients with PCOS report, we present the live birth of a healthy infant resulting are extremely sensitive to stimulation with exogenous gonadfrom transfer of frozen-thawed embryos produced from inotrophin and are at increased risk of developing ovarian vitro matured oocytes, which were cryopreserved at the hyperstimulation syndrome (OHSS) when treated with gonadpronuclear stage following intracytoplasmic sperm injection otrophins for assisted reproduction (MacDougall et al., 1993) .
(ICSI). To the best of our knowledge, this is the first report Recovery of immature oocytes followed by in-vitro maturation of the birth of an infant from cryopreserved embryos (zygotes) (IVM) of these oocytes could be developed as a new method produced by in-vitro matured oocytes derived from an for the treatment of patients with infertility due to PCOS. unstimulated patient with PCOS. Methods developed by Trounson for transvaginal ultrasound guided recovery of immature oocytes from the ovaries of patients with PCOS introduced IVM firmly into the clinical Case report realm (Trounson et al., 1994) . It has been noted that most of A 31 year-old woman with PCOS presented with irregular the follicles from patients with PCOS are not atretic and these menstrual cycles, anovulation and 4 years of infertility. She had oocytes appear to have developmental competence (Almahbobi failed to achieve pregnancy following 6 cycles of intrauterine et al., 1996; Barnes et al., 1996) . However, the maturation insemination (IUI) with her husband's spermatozoa combined rate of immature oocytes retrieved from women with PCOS with ovulation induction using clomiphene citrate or gonadotrois lower than that of those retrieved from women with normal phin therapy. The patient had hirsutism, a baseline LH/FSH menstrual cycles (Cha and Chian, 1998). It has been reported that priming with human chorionic gonadotrophin (HCG) ratio of 2.76, and enlarged polycystic ovaries which met the ultrasound diagnostic criteria of PCOS (Adams et al., 1986) . 3-cell stage grade 1, two 4-cell stage grade 3) were transferred at 48 h following ICSI. At embryo transfer, the endometrial Routine semen analysis on her husband indicated no abnormality. To initiate the treatment cycle the patient received thickness was 8.9 mm at transvaginal ultrasound scan. Embryo transfer was performed using a Wallace catheter (SIMS Protex intravaginal progesterone (Prometrium; Schering, Pointe-Clair, Quebec, Canada) in a dose of 300 mg a night for 10 days to Limited, Hythe, Kent, UK), and two weeks later the serum β-HCG level was 122.2 IU/l. Six weeks after embryo transfer induce a withdrawal bleed. After stopping the progesterone treatment, menstrual bleeding started 3 days later. She had a an ongoing intrauterine singleton pregnancy with fetal heartbeat was confirmed by transvaginal ultrasonography. Unfortunately, baseline ultrasound scan to ensure no ovarian cysts were present and transvaginal ultrasound scans were performed on this pregnancy miscarried at eight weeks after embryo transfer. Following maturation in culture for 48 h of the remaining day 6 and day 8 to exclude the development of a dominant follicle. Oocyte retrieval was performed on day 11. The patient 31 oocytes, 19 oocytes were at metaphase-II stage. After ICSI of those oocytes, 16 oocytes were observed to have 2PN. was administered 10 000 IU of HCG (Profasi; Serono, Oakville, ON, Canada) s.c. 36 h prior to immature oocyte collection.
These 16 fertilized oocytes were cryopreserved immediately after fertilization assessment. Embryo freezing was performed Transvaginal ultrasound guided oocyte collection was done using a specially designed aspiration needle (Cook, Eight Mile by the slow freezing protocol (Lassalle et al., 1985) . Briefly, 2PN oocytes were suspended for 20 min in 2 ml of cryoPlains, Queensland, Australia, K-OPS-1235-Wood) with an aspiration pressure of 7.5 kPa. Aspiration of all small follicles protectant (1.5 mol/l propanediol, 0.1 mol/l sucrose) in Dulbecco's phosphate-buffered saline (PBS; GIBCO BRL, (2-8 mm diameter) was attempted under spinal anesthesia. In total more than 70 follicles were aspirated from both ovaries.
Rockville, MD, USA) containing 30% human serum albumin solution (5% human albumin; Bayer, Elkhart, IN, USA). They Aspirates were collected in 10 ml culture tube (Falcon; Franklin Lakes, NJ, USA) containing 2 ml warm 0.9% saline with 2 were then aspirated into 0.25 ml straws (CryoBioSystem, Orsay, France) in a small central droplet of cryoprotectant IU/ml heparin (Baxter, Toronto, Canada). Following oocyte collection, the maturity of the oocytes was determined under surrounded by two air bubbles and adjacent cryoprotectant droplets. The straws were then frozen horizontally in a promicroscopy and the immature oocytes were then transferred to maturation medium for culture. All oocyte handling procedures grammable freezer (Planer Kryo 10 Series III; Planer Products Ltd., Sunbury-on-Thames, UK) using a slow-freezing protocol were conducted on warm stages and plates at 37°C. Cumulus oocyte complexes were washed in TC-199 medium (Sigma.
(-2°C/min to -7°C; hold at -7°C for 10 min and manual seeding; -0.3°C/min to -30°C; -50°C/min to -180°C, hold St Louis, MO, USA) with 10% patient's own serum (inactivated at 56°C for 30 min) and the immature oocytes were then at -180°C for 20 min and then plunge into liquid nitrogen). Thawing was performed by maintaining the straws first in air incubated in the maturation medium, TC-199 medium supplemented with 20% patient's own serum, 75 mIU/ml FSH ϩ for 10-15 sec and then plunging them into a water bath at 30°C for 30 sec. The central droplet, containing the 2PN LH (Humegon, Organon, Scarborough, ON, Canada) at 37°C in an atmosphere of 5% CO 2 in air for 48 h.
oocytes was then gently expelled from the straw in 2 ml of PBS containing 1 mol/l propanediol (PROH) and 0.2 mol/l After 24 and 48 h of incubation, mature oocytes were denuded of cumulus cells using finely drawn glass pipettes sucrose. The 2PN oocytes were then washed free of the cryprotectants by sequential incubation (10 min) in three following 1 min exposure to 0.1% hyaluronidase solution (Medi-Cult, Hopkinton, MA, USA). Spermatozoa for ICSI aliquots of PBS solution (2 ml) containing lowered molar concentrations of PROH/sucrose (0.5/0.2; 0/0.2; 0/0). were prepared by gradient separation (45 and 90% gradients) at 560 g for 20 min. Following gradient separation, the sperm Standard protocol was followed for the preparation of the endometrium for frozen embryo transfer. Briefly, the patient pellet was washed twice (200 g) with 5 ml of IVF medium (Medi-Cult Inc.). After ICSI, each oocyte was transferred to received intravaginal progesterone (Prometrium) in a dose of 300 mg a night for 10 days to induce a withdrawal bleed. 20 µl of Medi-Cult medium under mineral oil (Sigma) for culture. Fertilization was assessed 16-18 h after ICSI for the After stopping the progesterone, menstrual bleeding started in 3 days. On day 2 of the cycle, the patient was given 200 µg appearance of two distinct pronuclei (2PN) and two polar bodies. Fertilized 2PN oocytes were transferred to 1.0 ml of of the gonadotrophin-releasing hormone agonist, Buserelin (Suprefact Synthetic LH-RH analogue; Hoechst Marion Medi-Cult medium in two-well organ tissue culture dishes for a further 24 h. For the preparation of the endometrium, Roussel Canada Inc., Laval, Quebec, Canada) and 6 mg oestradiol (Estrace) daily for 10 days. Two days before the patient was given 4 mg of oestradiol (Estrace; Roberts Pharmaceutical, Mississauga, Canada) in divided doses starting embryo transfer, Busrelin was stopped and progesterone was administered vaginally (200 mg twice a day). on the day of oocyte retrieval. Luteal support was provided in the form of 200 mg progesterone (Prometrium) twice a day Three months after cryopreservation, nine fertilized oocytes were thawed for scheduled embryo transfer. Following thawing, for 16 days starting 48 h after oocyte collection.
A total of 63 oocytes were retrieved (10 with abnormal 8 fertilized oocytes survived (88.9%; 8/9) and 7 cleaved (87.5%). Three embryos were transferred (one 4-cell stage morphology, 22 at metaphase-I stage and 31 at germinal vesicle stage). Following maturation in culture for 24 h, 22 oocytes grade 2, two 4-cell stage grade 3). The endometrial thickness measured 9.0 mm on the day of embryo transfer. However, were noted to be at metaphase-II stage. After ICSI of the 22 oocytes, 15 were observed to have 2PN on the second day. Of after two weeks no pregnancy ensued as confirmed by a negative pregnancy test. The second frozen embryo transfer 15 fertilized oocytes 13 cleaved. A total of 3 embryos (one was performed 5 months later. The remaining 7 fertilized embryos produced by in-vitro matured oocytes are higher when frozen at the 2PN stage compared with the cleavage oocytes were thawed and all survived (100%; 7/7). After 24 h of culture, all embryos had cleaved (100%; 7/7). Three embryos stage (unpublished data). In conclusion, the embryos produced from in-vitro matured oocytes retrieved from unstimulated were transferred (two 4-cell stage grade 2 and one 4-cell stage grade 3). The endometrial thickness measured 9.5 mm on the women with PCOS can be safely cryopreserved and healthy infants can be delivered following embryo transfer. day of embryo transfer. Two weeks later, the serum β-HCG concentration was 258.5 IU/l and 6 weeks after embryo transfer an ongoing intrauterine singleton pregnancy with fetal heartbeat References was confirmed by transvaginal ultrasonography. An uneventful Adams, J., Polson, D., Frank, S. et al. (1986) Prevalence of polycystic ovaries delivery at 38.5 weeks resulted in the birth of a normal healthy in women with anovulation and idiopathic hirsutism. Br. Med. J., 293, [355] [356] [357] [358] [359] boy (3040 g).
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